Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.

Biotechnology

Pharmaceutical

Infinity Pharmaceuticals

Seth Tasker

Khaled Oukasha

Kenneth Duong

Deirdre Casale

Naglaa Fikry

Somarajan Nair

Steve Cucinotta

Linda Dai Cpa, Mpacc

Nora Zizlsperger

Feng Chai

Joseph McPherson

Jennifer B.

Christine Paiva

Liya Megerssa

Infinity Pharmaceuticals' CEO and Executive Team includes Adelene Perkins and 3 others.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Infinity Pharmaceuticals

Board of Directors

Leadership Team